A historic shift in our drug policy has happened, as the regulators permit the availability of psilocybin mushrooms for therapeutic treatment. Previously, these substances were strictly restricted, but a increasing body of studies suggests they could offer relief for emotional illnesses like PTSD. This development represents a key step toward re-ev